Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAN 2024 | Treating myasthenia gravis in pregnancy

Jenny Lindroos, MD, University of Bergen, Bergen, Norway, discusses the concerns that many women with myasthenia gravis have about taking medication during pregnancy. Dr Lindroos emphasizes the importance of early discussions about safe medications, noting that while some drugs like methotrexate and mycophenolate are unsafe, others like prednisolone and azathioprine are relatively safe. Pyridostigmine has been used for many years in pregnancy without evidence of harm, though there are theoretical risks like pre-term contractions. Dr Lindroos reassures women that data show most pregnancies are normal, with spontaneous vaginal births being the goal unless complications arise. This interview took place at the European Academy of Neurology (EAN) Annual Meeting 2024 in Helsinki, Finland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.